Lazard Ltd
Lazard Ltd (LAZ) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Lazard Ltd (LAZ), covering cash flow, earnings, and balance sheets.
Lazard Ltd (LAZ) Income Statement & Financial Overview
View the income breakdown for Lazard Ltd LAZ across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $657.50M | $824.74M | $792.41M | $695.14M |
| Cost of Revenue | $449.11M | $534.42M | $519.20M | $452.56M |
| Gross Profit | $220.06M | $290.32M | $288.22M | $242.58M |
| Gross Profit Ratio | $0.33 | $0.35 | $0.36 | $0.35 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $108.53M | $112.25M | $103.57M | $108.37M |
| Operating Expenses | $172.60M | $183.24M | $165.82M | $178.94M |
| Total Costs & Expenses | $602.87M | $717.66M | $631.22M | $629.59M |
| Interest Income | $11.66M | $14.27M | $15.005M | $12.85M |
| Interest Expense | $21.11M | $22.15M | $22.55M | $22.64M |
| Depreciation & Amortization | $8.44M | $9.00M | $9.02M | $9.20M |
| EBITDA | $84.19M | $138.04M | $192.75M | $95.53M |
| EBITDA Ratio | $0.13 | $0.17 | $0.24 | $0.14 |
| Operating Income | $54.63M | $107.08M | $161.19M | $63.64M |
| Operating Income Ratio | $0.08 | $0.13 | $0.20 | $0.09 |
| Other Income/Expenses (Net) | -$1.61M | $8.01M | -$8.20M | -$2.14M |
| Income Before Tax | $54.63M | $107.08M | $161.19M | $63.64M |
| Income Before Tax Ratio | $0.08 | $0.13 | $0.20 | $0.09 |
| Income Tax Expense | -$7.35M | $28.79M | $45.05M | $11.59M |
| Net Income | $60.38M | $86.31M | $107.94M | $49.91M |
| Net Income Ratio | $0.09 | $0.10 | $0.14 | $0.07 |
| EPS | $0.61 | $0.89 | $1.13 | $0.53 |
| Diluted EPS | $0.56 | $0.80 | $1.02 | $0.49 |
| Weighted Avg Shares Outstanding | $95.25M | $94.78M | $93.63M | $92.89M |
| Weighted Avg Shares Outstanding (Diluted) | $104.83M | $106.11M | $103.47M | $100.63M |
Financial performance has remained strong, with revenue growing from $695.14M in Q2 2024 to $657.50M in Q1 2025. Gross profit continued to perform well, with margins at 33% in the latest quarter. Operating income reached $54.63M in Q1 2025, holding a steady 8% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $84.19M. Net income dropped to $60.38M, keeping EPS at $0.61. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan